• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有作为涂层药物的西罗莫司的药物洗脱支架的释放动力学:释放介质的作用。

The release kinetics of drug eluting stents containing sirolimus as coated drug: role of release media.

机构信息

Laboratory for Polymer Analysis, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences & Technology, Poojapura, Trivandrum 695012, Kerala, India.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Mar 1;878(7-8):709-12. doi: 10.1016/j.jchromb.2010.01.023. Epub 2010 Jan 25.

DOI:10.1016/j.jchromb.2010.01.023
PMID:20138593
Abstract

Prior understanding on the in vitro release profile of the drug from drug eluting devices such as stent (DES) is crucial in designing and optimizing the drug embedded coating or matrices. In fact, assessing in vitro release profile is a mandatory requirement prior to the clinical evaluation of DES. The in vitro release is also employed to estimate parameters such as T1/2. The release profile largely depends on the release medium selected for the studies. Normally PBS with a pH of 7.4 is used for assessing the release kinetics of the drug. Often drug undergoes irreversible changes such as hydrolysis in PBS leading to erroneous assessment of the release profile. This is particularly true in the case of sirolimus, one of the widely used drugs in various applications. We studied the influence of various media on the release profile of sirolimus from DES. The data generated suggested that a release medium consisting of 9:1 (v/v) of normal saline and isopropanol is a most suitable one for assessing in vitro the release kinetics of sirolimus from DES.

摘要

在设计和优化药物嵌入涂层或基质之前,了解药物洗脱器械(如支架)中药物的体外释放情况至关重要。事实上,评估体外释放情况是 DES 临床评估之前的强制性要求。体外释放也可用于估计 T1/2 等参数。释放曲线在很大程度上取决于研究中选择的释放介质。通常使用 pH 值为 7.4 的 PBS 来评估药物的释放动力学。药物通常会发生不可逆的变化,如在 PBS 中水解,从而导致对释放曲线的错误评估。对于西罗莫司(广泛用于各种应用的药物之一)尤其如此。我们研究了不同介质对 DES 中西罗莫司释放曲线的影响。生成的数据表明,由生理盐水和异丙醇 9:1(v/v)组成的释放介质是评估 DES 中西罗莫司体外释放动力学的最适合介质。

相似文献

1
The release kinetics of drug eluting stents containing sirolimus as coated drug: role of release media.载有作为涂层药物的西罗莫司的药物洗脱支架的释放动力学:释放介质的作用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Mar 1;878(7-8):709-12. doi: 10.1016/j.jchromb.2010.01.023. Epub 2010 Jan 25.
2
Preparation and optimization of media using Pluronic® micelles for solubilization of sirolimus and release from the drug eluting stents.使用普朗尼克胶束制备和优化介质以增溶西罗莫司并从药物洗脱支架中释放。
Colloids Surf B Biointerfaces. 2012 May 1;93:180-7. doi: 10.1016/j.colsurfb.2011.12.034. Epub 2012 Jan 8.
3
Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.药物洗脱可生物降解聚合物涂层控释支架的制备及其体外释放曲线
Colloids Surf B Biointerfaces. 2009 Oct 15;73(2):199-206. doi: 10.1016/j.colsurfb.2009.05.016. Epub 2009 May 27.
4
Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.经皮冠状动脉介入治疗的最新进展:药物洗脱支架的演变,聚焦于XIENCE V药物洗脱支架。
Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.
5
In vitro and in vivo performance of a dual drug-eluting stent (DDES).一种双重药物洗脱支架(DDES)的体内外性能。
Biomaterials. 2010 May;31(15):4382-91. doi: 10.1016/j.biomaterials.2010.01.147. Epub 2010 Feb 26.
6
In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents.载药支架中 PLGA/西罗莫司涂层的体外和体内变化。
Biomaterials. 2010 Jul;31(19):5151-8. doi: 10.1016/j.biomaterials.2010.02.003. Epub 2010 Apr 10.
7
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).西罗莫司洗脱支架、紫杉醇洗脱支架和裸金属支架置入后的临床结局(来自前瞻性多中心德国DES.DE注册研究的第一阶段)
Am J Cardiol. 2009 Nov 15;104(10):1362-9. doi: 10.1016/j.amjcard.2009.06.058. Epub 2009 Sep 26.
8
[Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].[德国西罗莫司洗脱冠状动脉支架“实际使用”中的安全性及当前适应证。德国前瞻性多中心西罗莫司洗脱支架注册研究结果]
Herz. 2004 Mar;29(2):181-6. doi: 10.1007/s00059-004-2560-x.
9
Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.一种新型药物洗脱支架系统对新生内膜形成的抑制作用,该系统可实现剂量可调、多次及原位支架涂层。
Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):748-53. doi: 10.1161/01.ATV.0000157579.52566.ee. Epub 2005 Jan 27.
10
Carrier free rapamycin loaded drug eluting stent: in vitro and in vivo evaluation.载无载体雷帕霉素药物洗脱支架:体外和体内评价。
J Control Release. 2013 May 28;168(1):70-6. doi: 10.1016/j.jconrel.2013.02.012. Epub 2013 Feb 24.

引用本文的文献

1
The Increased Release Kinetics of Quercetin from Superparamagnetic Nanocarriers in Dialysis.超顺磁性纳米载体中槲皮素在透析过程中释放动力学的增强
Antioxidants (Basel). 2023 Mar 16;12(3):732. doi: 10.3390/antiox12030732.
2
An Overview of In Vitro Drug Release Methods for Drug-Eluting Stents.药物洗脱支架的体外药物释放方法概述
Polymers (Basel). 2022 Jul 5;14(13):2751. doi: 10.3390/polym14132751.
3
The Development of Design and Manufacture Techniques for Bioresorbable Coronary Artery Stents.生物可吸收冠状动脉支架的设计与制造技术发展
Micromachines (Basel). 2021 Aug 20;12(8):990. doi: 10.3390/mi12080990.
4
and evaluation of a dextran-graft-polybutylmethacrylate copolymer coated on CoCr metallic stent.以及对涂覆在钴铬金属支架上的葡聚糖接枝聚甲基丙烯酸丁酯共聚物的评估。
Bioimpacts. 2019;9(1):25-36. doi: 10.15171/bi.2019.04. Epub 2018 Oct 2.
5
Non-polymer drug-eluting coronary stents.非聚合物药物洗脱冠状动脉支架。
Drug Deliv Transl Res. 2018 Aug;8(4):903-917. doi: 10.1007/s13346-017-0414-3.
6
Modelling the Impact of Atherosclerosis on Drug Release and Distribution from Coronary Stents.模拟动脉粥样硬化对冠状动脉支架药物释放和分布的影响。
Ann Biomed Eng. 2016 Feb;44(2):477-87. doi: 10.1007/s10439-015-1456-7. Epub 2015 Sep 18.
7
Electrospun rapamycin-eluting polyurethane fibers for vascular grafts.用于血管移植物的电纺雷帕霉素洗脱型聚氨酯纤维
Pharm Res. 2013 Jul;30(7):1735-48. doi: 10.1007/s11095-013-1016-5. Epub 2013 Apr 9.